Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 9

    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Farhat Nasim23 Sept 2019 5:46 PM IST
    New Delhi: The Drugs Consultative Committee (DCC), functional under Central Drugs Standard Control Organisation (CDSCO), recently recommended the...
    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    Medical Dialogues Bureau22 Sept 2019 11:30 AM IST
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation(CDSCO) has directed all the manufacturers of Fixed-Dose...
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat Nasim21 Sept 2019 3:21 PM IST
    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
    No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

    No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

    Medical Dialogues Bureau20 Sept 2019 4:02 PM IST
    V G Somani said, according to the information he had the impurities were not found during the initial approval process of the product (Valsartan)....
    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Medical Dialogues Bureau20 Sept 2019 2:33 PM IST
    The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT...
    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Farhat Nasim19 Sept 2019 3:17 PM IST
    New Delhi: Taking cognizance of the grave concern of providing security and protection to Drug inspectors from threats, the Drugs Consultative...
    Manufacture of Class C, D medical devices: CDSCO makes Centre the licensing authority

    Manufacture of Class C, D medical devices: CDSCO makes Centre the licensing authority

    Farhat Nasim17 Sept 2019 5:03 PM IST
    New Delhi: Through a recent Gazette notification, the Central Drugs Standard Control Organisation (CDSCO) has apprised that medical device...
    CDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API consignments for Exports

    CDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API consignments for Exports

    Farhat Nasim15 Sept 2019 10:36 AM IST
    New Delhi: Through a recent circular, the Central Drugs Standard Control Organisation (CDSCO) has apprised about maintaining the continuity in the...
    One Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional sites

    One Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional sites

    Farhat Nasim14 Sept 2019 4:38 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has apprised drug makers that they can manufacture a new...
    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Farhat Nasim11 Sept 2019 6:42 PM IST
    New Delhi: The apex drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has apprised about the positive impact of capping...
    Incorporate Good Distribution Practices guidelines as separate Schedule in Drugs and Cosmetics Rules, 1945: DTAB recommendation

    Incorporate Good Distribution Practices guidelines as separate Schedule in Drugs and Cosmetics Rules, 1945: DTAB recommendation

    Medical Dialogues Bureau9 Sept 2019 3:56 PM IST
    New Delhi: In a move to provide quality drugs to patients, the Drugs Technical Advisory Board (DTAB) has recently recommended to include provisions on...
    Pharma, Bio-Pharma manufacturing units to follow Apprentices Act: CDSCO issues advisory

    Pharma, Bio-Pharma manufacturing units to follow Apprentices Act: CDSCO issues advisory

    Farhat Nasim8 Sept 2019 4:34 PM IST
    New Delhi: Through a recent advisory, the apex drug regulatory body- Central Drugs Standard Control Organization (CDSCO) has directed all...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok